-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Georgetown has once again been classified by the Carnegie Classification of Institutions of Higher Education as an institution with “very high research activity.”
Category: Lombardi Stories
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
A new study conducted at cancer centers around the country, including at Georgetown Lombardi Comprehensive Cancer Center, supports the routine use of a radiation treatment for prostate cancer that delivers a high dose of therapy in a very short time frame.
Category: News Release
-
Jill Biden Joins Washington Area Anchorwomen to Raise Funds for Georgetown’s Capital Breast Care Center
Former second lady of the United States Jill Biden joined supporters, survivors, politicos and friends for the annual NewsBash event, which helps raise awareness for breast cancer and this year raised funds for Georgetown’s Capital Breast Care Center.
Category: Lombardi Stories
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Walking Warriors Host Grand Start Party, Launching 2019 Fundraising Efforts
To launch the start of training season for their Second Annual Walk, the Walking Warriors Battling Breast Cancer held a grand start party attended by dozens of breast cancer survivors and their friends and family.
Category: Lombardi Stories
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center, a mother of two and grandmother of four, is now in “complete remission” after a lengthy battle with stage-three non-Hodgkin lymphoma.
Category: Lombardi Stories
-
Movement for Multiple Sclerosis (MS) Program
The Movement for Multiple Sclerosis (MS) Program, first piloted by Georgetown University Medical Center and MedStar Georgetown University Hospital in November 2017, offers an innovative music and movement based course for patients with multiple sclerosis.
Category: Lombardi Stories
-
Giving Patients a Voice in Breast Cancer Research
The members of Georgetown Breast Cancer Advocates are all volunteers and breast cancer survivors who are committed to supporting and promoting breast cancer research.
Category: Lombardi Stories
-
Georgetown Genetic Counselor Offers Insight on Direct-to-Consumer DNA Testing Kits
Direct-to-consumer DNA testing kits have become popular holiday gifts. However, genetic counselor Beth N. Peshkin, MS, LCGC, of Georgetown University School of Medicine and Georgetown Lombardi Comprehensive Cancer Center encourages consumers to understand the pros and cons before gifting or using one of these kits.
Category: News Release
-
Georgetown Lombardi’s Louis M. Weiner, MD, Named a National Academy of Inventors Fellow
The National Academy of Inventors has named Louis M. Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center, to its 2018 class of fellows.
Category: News Release
